NSC
62
-5
QCOM
55
-4
ITW
62
-2
RF
51
-2
DUK
64
2
SO
66
2
LB
38
-7
AMG
41
-3
SWN
77
4
BRK.B
42
-3
CFG
38
-2
D
60
5
ETR
68
2
IR
72
-5
O
31
3
WAT
54
2
XRX
52
-3
DE
53
8
LLY
48
-2
UA
32
8
NSC
62
-5
QCOM
55
-4
ITW
62
-2
RF
51
-2
DUK
64
2
SO
66
2
LB
38
-7
AMG
41
-3
SWN
77
4
BRK.B
42
-3
CFG
38
-2
D
60
5
ETR
68
2
IR
72
-5
O
31
3
WAT
54
2
XRX
52
-3
DE
53
8
LLY
48
-2
UA
32
8
Financhill
Back

iShares Morningstar Mid-Cap ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
59

IMCB
iShares Morningstar Mid-Cap ETF

Last Price:
75.25
Seasonality Move:
1.55%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
59
iShares Morningstar Mid-Cap ETF (IMCB) is a Buy

Is iShares Morningstar Mid-Cap ETF a Buy, Sell or Hold?

  • The current iShares Morningstar Mid-Cap ETF [IMCB] share price is $75.41. The Score for IMCB is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • IMCB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

IMCB Stock Price Chart

What is iShares Morningstar Mid-Cap ETF's stock price today?

  • The iShares Morningstar Mid-Cap ETF share price today is $75.41
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMCB is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

IMCB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.76 Buy
Relative Strength Index (14 RSI): 64.84 Buy
Chaikin Money Flow: 10195 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.78 - 74.66) Buy
Bollinger Bands (100): (69.97 - 73.19) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

IMCB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 74.53 Buy
20-day SMA: 73.91 Buy
50-day SMA: 72.64 Buy
200-day SMA: 69.98 Buy
8-day EMA: 74.7 Buy
20-day EMA: 73.88 Buy
50-day EMA: 72.81 Buy
200-day EMA: 69.73 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

iShares Morningstar Mid-Cap ETF Earnings Growth & IMCB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

iShares Morningstar Mid-Cap ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):